ALSEN.PA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:54):

Stats
Today's Volume	475.00
Average Volume	123 420
Market Cap	219.87M
EPS	€0 ( 2024-03-14 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-4.12
ATR14	€0.00500 (0.71%)

Sensorion SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sensorion SA Financials

Annual	2023
Revenue:	€4.74M
Gross Profit:	€3.79M (79.86 %)
EPS:	€-0.170

Q4	2023
Revenue:	€3.01M
Gross Profit:	€2.53M (84.10 %)
EPS:	€-0.0523

Q2	2023
Revenue:	€2.55M
Gross Profit:	€2.08M (81.34 %)
EPS:	€-0.150

Q4	2022
Revenue:	€0
Gross Profit:	€-393 064 (0.00 %)
EPS:	€-0.140

Financial Reports:

No articles found.

Sensorion SA

Sensorion SA, a clinical-stage biopharmaceutical company, develops drug candidates for the treatment of inner ear disorders in France. The company develops OTOF-GT, a gene therapy development program to restore hearing in people living with Otoferlin deficiency; USHER-T1-GT, a gene therapy development program to for patients suffering from usher syndrome Type 1; and SENS-401, a drug candidate to treat sudden sensorineural hearing loss. Its pipeline also includes various products in development stage for restoring, treating, and preventing inner ear related disorders. The company has a collaboration agreement with Institut Pasteur for gene therapy program for pediatric and adult deafness; and with Sonova Holding AG to introduce genetic analysis for routine diagnosis of progressive hearing loss in adults through a combination of advanced therapeutic interventions and traditional hearing aids. Sensorion SA was founded in 2009 and is headquartered in Montpellier, France.